MedTrace Logo

Mechanisms of Prediabetic States in Sleep Apnea

NCT04234217 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 300

Last updated 2026-04-24

No results posted yet for this study

Summary

The purpose of this study is to better understand how sleep apnea contributes to the development of diabetes.

Conditions

Interventions

DEVICE

Continuous positive airway pressure

Continuous positive airway pressure (CPAP) treatment of obstructive sleep apnea (OSA)

OTHER

Niacin

Suppression of lipolysis by niacin infusion

Sponsors & Collaborators

  • Mayo Clinic

    collaborator OTHER

  • National Heart, Lung, and Blood Institute (NHLBI)

    collaborator NIH

  • AdventHealth

    collaborator OTHER

  • University of Chicago

    lead OTHER

Principal Investigators

  • Esra Tasali, MD · University of Chicago

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
20 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-11-26
Primary Completion
2026-07-15
Completion
2026-07-15
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04234217 on ClinicalTrials.gov